• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

DEVELOPMENT OF A NOVEL THERAPEUTIC DRUG FOR TREATMENT OF PRETERM DELIVERY

Research Project

Project/Area Number 18591791
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionHirosaki University

Principal Investigator

TANAKA Kanji  Hirosaki University, Hirosaki University School of Medicine Department of Obstetrics and Gynecology, Assistant Professor (20311540)

Co-Investigator(Kenkyū-buntansha) HIGUCHI Tsuyoshi  Hirosaki University School of Medicine Department of Obstetrics and Gynecology, 医学部附属病院, Assistant Professor (60238285)
OZAKI Takashi  Hirosaki University School of Medicine Department of Obstetrics and Gynecology, 医学部附属病院, Associate Professor (80260404)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥2,470,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥270,000)
Fiscal Year 2007: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordspreterm delivery / proteoglycan / inflammatory cytokine / cultured fibroblast from human uterine cervix / chorioamnionitis / urinastatin / 周産期医学 / 早産
Research Abstract

Objectives: Chorioamnionitis (CAM) is an extremely important factor in preterm delivery, and various inflammatory cytokines of amnionic fluid have important roles in the onset of CAM and cervical ripening. Proteoglycan (PG) was a main component of the extracellular matrix and its anti-inflammatory effects have attracted particular attention. In this study, the effect of PG on inflammatory cytokines was investigated in LPS-stimulated cultured fibroblasts from the uterine cervix.
Marerials and Methods: A specimen of normal human uterine cervix was collected after a total hysterectomy for uterine myoma at Hirosaki University Hospital. This tissue sample was cut into small pieces, which were then incubated in Dulbecco's modified Eagle medium containing 10% fetal bovine serum in a humidified atmosphere 5% CO_2/95% air at 37℃. After the fibroblasts had grown to confluency, they were used at up to sixth passage for the following experiments. Uterine cervical fibroblasts were incubated with or … More without Proteoglycan (0.5 mg/ml, 1 mg/ml) and LPS (1 μ g/ml) for 48 h, and a medium fraction was obtained. The amounts of IL-1β, IL-6 and IL-8 in the medium were assayed by the ELISA method.
Results: In the medium, the amount of IL-1β produced by cultured fibroblasts from the uterine cervix increased and reached a peak 12 hours after the addition of LPS, but later this amount decreased gradually. The addition of PG to the medium of cultured cells reduced IL-1β in a dose-dependent manner. Incubated with 1 mg/ml PG and LPS, IL-1β was suppressed by 58% compared with the controls. The amount of IL-6 produced by the same cell in the amount of IL-6 in a dose-dependent manner. Incubated with 1 mg/ml PG and LPS, IL-6 was significantly decreased in comparison with the controls at all times. The amount of IL-8 produced by the same cell in the medium increased linearly with time, but IL-8 production decreased with an increase in PG concentration. In the presence of 0.5 and 1.0 mg/ml PG, IL-8 production was decreased by about 20% and 30.1% of the control level.
Conclusions: The results of the current study indicate that preterm delivery may be suppressed by PG since it inhibited various inflammatory cytokines that mainly contribute to the onset of CAM and cervical ripening. Less

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (8 results)

All 2007

All Journal Article (3 results) (of which Peer Reviewed: 2 results) Presentation (5 results)

  • [Journal Article] 4-Methylumbelliferone inhibits hyaluronate synthesis in human uterine cervical fibroblasts2007

    • Author(s)
      Kanji Tanaka et. al.
    • Journal Title

      J. Obstet. Gynaecol. Res 33

      Pages: 772-776

    • NAID

      10020002057

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] 4-Methylumbelliferone inhibits hyaluronate synthesis in human uterine cervical fibroblasts2007

    • Author(s)
      Kanji Tanaka, Ryousuke Taniguchi, Tsuyoshi Higuchi, Takashi Ozaki, Hideki Mizunuma, Keiichi Takagaki
    • Journal Title

      JOGR Vol. 33

      Pages: 772-776

    • NAID

      10020002057

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] 4-Methylumbelliferone inhibits hyaluronate synthesis in human uterine cervical fibroblasts2007

    • Author(s)
      Kanji Tanaka, et. al.
    • Journal Title

      J. Obstet. Gynaecol. Res 33

      Pages: 772-776

    • NAID

      10020002057

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Presentation] プロテオグリカンを用いた新規切迫早産治療薬の開発2007

    • Author(s)
      田中幹二
    • Organizer
      第43回日本周産期・新生児学会学術集会
    • Place of Presentation
      グランドプリンスホテル赤坂
    • Year and Date
      2007-07-09
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] DEVELOPMENT OF A NOVEL THERAPEUTIC DRUG FOR TREATMENT OF PRETERM EDLIVERY2007

    • Author(s)
      Kanji Tanaka
    • Organizer
      43^<th> Annual congress of the Japan society of perinatal and neonatal medicine
    • Place of Presentation
      Tokyo
    • Year and Date
      2007-07-09
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] プロテオグリカンを用いた新規切迫早産治療薬の開発2007

    • Author(s)
      田中幹二
    • Organizer
      日本産科婦人科学会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2007-04-15
    • Related Report
      2007 Annual Research Report
  • [Presentation] プロテオグリカンを用いた新規切迫早産治療薬の開発2007

    • Author(s)
      田中幹二
    • Organizer
      第59回日本産科婦人科学会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2007-04-13
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] DEVELOPMENT OF A NOVEL THERAPEUTIC DRUG FOR THEATMENT OF PRETERM DELIVERY2007

    • Author(s)
      Kanji Tanaka
    • Organizer
      59^<th> Annual congress of the Japan society of obstetrics and gynecology
    • Place of Presentation
      Kyoto
    • Year and Date
      2007-04-13
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi